chloroquine has been researched along with Asymptomatic Conditions in 5 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was an open-label, non-comparative study (NCT01103713) in 5 countries in East and sub-Saharan Africa (Benin, Kenya, Malawi, Tanzania, and Uganda) to assess parasitological response and drug concentrations of a single, 3-day course of four tablets of a fixed-dose combination of azithromycin-chloroquine (AZCQ) 250/155 mg given during the second or third trimester to women with asymptomatic Plasmodium falciparum parasitemia in their first or second pregnancy." | 9.22 | Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. ( Ayoub, A; Duparc, S; Kimani, J; Mtove, GA; Phiri, K; Robbins, J; Rojo, R; Vandenbroucke, P; Zhao, Q, 2016) |
| "This was an open-label, non-comparative study (NCT01103713) in 5 countries in East and sub-Saharan Africa (Benin, Kenya, Malawi, Tanzania, and Uganda) to assess parasitological response and drug concentrations of a single, 3-day course of four tablets of a fixed-dose combination of azithromycin-chloroquine (AZCQ) 250/155 mg given during the second or third trimester to women with asymptomatic Plasmodium falciparum parasitemia in their first or second pregnancy." | 5.22 | Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. ( Ayoub, A; Duparc, S; Kimani, J; Mtove, GA; Phiri, K; Robbins, J; Rojo, R; Vandenbroucke, P; Zhao, Q, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gegúndez-Fernández, JA | 1 |
| Zarranz-Ventura, J | 1 |
| Garay-Aramburu, G | 1 |
| Muñoz-Negrete, FJ | 1 |
| Mendicute Del Barrio, J | 1 |
| Pablo-Júlvez, L | 1 |
| García-Delpech, S | 1 |
| López-Alemany, A | 1 |
| Arnalich-Montiel, F | 1 |
| Cordero-Coma, M | 1 |
| Cárceles, JA | 1 |
| Aninagyei, E | 1 |
| Duedu, KO | 1 |
| Rufai, T | 1 |
| Tetteh, CD | 1 |
| Chandi, MG | 1 |
| Ampomah, P | 1 |
| Acheampong, DO | 1 |
| Nachega, JB | 1 |
| Ishoso, DK | 1 |
| Otokoye, JO | 1 |
| Hermans, MP | 1 |
| Machekano, RN | 1 |
| Sam-Agudu, NA | 1 |
| Bongo-Pasi Nswe, C | 1 |
| Mbala-Kingebeni, P | 1 |
| Madinga, JN | 1 |
| Mukendi, S | 1 |
| Kolié, MC | 1 |
| Nkwembe, EN | 1 |
| Mbuyi, GM | 1 |
| Nsio, JM | 1 |
| Mukeba Tshialala, D | 1 |
| Tshiasuma Pipo, M | 1 |
| Ahuka-Mundeke, S | 1 |
| Muyembe-Tamfum, JJ | 1 |
| Mofenson, L | 1 |
| Smith, G | 1 |
| Mills, EJ | 1 |
| Mellors, JW | 1 |
| Zumla, A | 1 |
| Mavungu Landu, DJ | 1 |
| Kayembe, JM | 1 |
| Raccurt, CP | 1 |
| Brasseur, P | 1 |
| Lemoine, F | 1 |
| Cicéron, M | 1 |
| Existe, A | 1 |
| Boncy, J | 1 |
| Phiri, K | 1 |
| Kimani, J | 1 |
| Mtove, GA | 1 |
| Zhao, Q | 1 |
| Rojo, R | 1 |
| Robbins, J | 1 |
| Duparc, S | 1 |
| Ayoub, A | 1 |
| Vandenbroucke, P | 1 |
1 review available for chloroquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Topics: Antimalarials; Asymptomatic Diseases; Betacoronavirus; Blood Safety; Chloroquine; Contact Lenses; Co | 2020 |
1 trial available for chloroquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa.
Topics: Adolescent; Adult; Africa South of the Sahara; Asymptomatic Diseases; Azithromycin; Chloroquine; Dru | 2016 |
3 other studies available for chloroquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Characterization of putative drug resistant biomarkers in Plasmodium falciparum isolated from Ghanaian blood donors.
Topics: Adolescent; Adult; Alleles; Antimalarials; Asymptomatic Diseases; Biomarkers; Blood Donors; Chloroqu | 2020 |
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.
Topics: Adolescent; Adult; Asymptomatic Diseases; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatme | 2020 |
[Epidemiological characteristics of malaria in the village of Corail, Grand'Anse, Haiti].
Topics: Adolescent; Adult; Aged; Antimalarials; Asymptomatic Diseases; Child; Child, Preschool; Chloroquine; | 2014 |